A. Burchert et al., CD82 (KAI1), a member of the tetraspan family, is expressed on early haemopoietic progenitor cells and up-regulated in distinct human leukaemias, BR J HAEM, 107(3), 1999, pp. 494-504
CD82 (KAI1) is a member of the tetraspan transmembrane protein family which
has been cloned from lpmphoblastoid variant cell lines. However, a role fo
r CD82 in early normal and malignant haemopoiesis has not yet been characte
rized. We studied the CD82 expression in 33 normal donor samples and 98 leu
kaemias by fluorescence activated cell sorting (FACS) and reverse transcrip
tase polymerase chain reaction (RT-PCR). We demonstrated that CD82 was mode
rately expressed in the vast majority of normal granulocytes and monocytes.
Ln contrast, only about one third of the peripheral blood lymphocytes were
weakly CD82 positive (CD82(+)). Interestingly judgement of the CD82 transc
ription and expression in various leukaemias revealed that CD82 was overexp
ressed in chronic myeloid leukaemia (CML) patients in accelerated or blasti
c phase (CML-AP/BP) as well as in acute myeloid leukaemia (AML) and chronic
lymphocytic leukaemia (CLL) patients. Analysis of AML patients with CD34()/CD82(+) blasts prompted us to expand our studies on haemopoietic CD34(+)
progenitor cells. Intriguingly, 84-95% of the CD34(+) cells isolated from h
ealthy bone marrow cord blood or peripheral blood were highly CD82(+), CD82
was abundantly expressed on primitive as well as on committed haemopoietic
progenitor cells. After in vitro induction of myeloid differentiation in C
D34(+) peripheral blood progenitor cells (PBPC), the expression of CD82 dec
reased to levels similar to those found on peripheral blood granulocytes. T
hese observations suggest for the first time a role for CD82 in normal and
malignant haemopoiesis.